Radiation therapy of sinonasal natural killer/T-cell lymphoma

被引:2
|
作者
Riet, F. -G. [1 ]
Canova, C. -H. [1 ]
Gabarre, J. [2 ]
Ben Hassine, S. [1 ]
Kom, L. Kamsu [1 ]
Mazeron, J. -J. [1 ]
Feuvret, L. [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Oncol Radiotheapie, F-75651 Paris 13, France
[2] Grp Hosp Pitie Salpetriere, AP HP, Serv Hepatol, F-75651 Paris 13, France
来源
CANCER RADIOTHERAPIE | 2014年 / 18卷 / 02期
关键词
Natural killer (NK)/T-cell lymphoma; Nasal cavity; Radiation therapy; Chemotherapy; Combined chemoradiation; INTENSITY-MODULATED RADIOTHERAPY; WORLD-HEALTH-ORGANIZATION; INTERNATIONAL PROGNOSTIC INDEX; STAGE NASOPHARYNGEAL CARCINOMA; INVOLVED-FIELD RADIATION; ANGIOCENTRIC T-CELL; NASAL-TYPE; (NK)/T-CELL LYMPHOMA; SMILE CHEMOTHERAPY; SINGLE-CENTER;
D O I
10.1016/j.canrad.2013.11.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK)/T-cell lymphoma are part of lymphoproliferative diseases, they are rare in Europe and the United States but relatively common in Asia and South America. Natural killer (NK)/T-cell lymphoma present clinically as destructive lesions of the upper aerodigestive tract with perforation of deep structures of the face, destruction of the palate or an invasion of orbits. Treatment modalities of these lymphomas are still discussed because of the lack of available studies and the rarity of this disease. Radiotherapy provides a rapid control of the disease and is positioned as a major treatment of localized stages of NK/T-cell lymphoma of the nasal cavity. We therefore studied the different forms of radiation therapy in the early stages of nasal NK/T-cell lymphoma. (C) 2013 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [21] Iris Involvement in Natural Killer/T-cell Lymphoma
    Yuka Shimonagano
    Kumiko Nakao
    Taiji Sakamoto
    Kimiharu Uozumi
    Koichi Haraguchi
    Japanese Journal of Ophthalmology, 2006, 50 : 557 - 558
  • [22] Primary Pancreatic Natural Killer/T-Cell Lymphoma
    Chon, Hyung Ku
    Choi, Keum Ha
    Kim, Tae Hyeon
    PANCREAS, 2020, 49 (03) : E21 - E23
  • [23] Practical management of natural killer/T-cell lymphoma
    Tse, Eric
    Kwong, Yok-Lam
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (05) : 480 - 486
  • [24] Primary cutaneous natural killer/T-cell lymphoma
    Bastian, BC
    Ott, G
    Müller-Deubert, S
    Bröcker, EB
    Müller-Hermelink, HK
    ARCHIVES OF DERMATOLOGY, 1998, 134 (01) : 109 - 111
  • [25] Genetic susceptibility to natural killer T-cell lymphoma
    Kucuk, Can
    LANCET ONCOLOGY, 2020, 21 (02): : 196 - 197
  • [26] Mimicking Gastric Natural Killer/T-Cell Lymphoma
    Ogawa, Satoshi
    Imai, Yukihiro
    Inokuma, Tetsuro
    GASTROENTEROLOGY, 2017, 153 (01) : E22 - E23
  • [27] Radiation Therapy Alone Not Inferior to Chemoradiation in the Patients With Stage I Nasal Natural Killer/T-Cell Lymphoma
    Ma, X.
    Guo, Y.
    Pan, Z.
    Li, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E451 - E452
  • [28] Extranodal natural killer/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified
    Hayashino, Kenta
    Yoshida, Chikamasa
    Ayata, Yoshiyuki
    Yukawa, Ryouya
    Komura, Aya
    Nakamura, Makoto
    Meguri, Yusuke
    Yamamoto, Kazuhiko
    Oda, Wakako
    Imajo, Kenji
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (01) : 52 - 58
  • [29] T-cell lymphoma associated with natural killer-like T-cell reaction
    Sun, T
    Susin, M
    Brody, J
    Tack, K
    Marsh, J
    Teichberg, S
    Koduru, P
    Schwartz, P
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (04) : 331 - 337
  • [30] Sinonasal NK/T-cell lymphoma
    Hmidi, M.
    Kettani, M.
    Elboukhari, A.
    Touiheme, N.
    Messary, A.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2013, 130 (03) : 145 - 147